- Compound-Enabling.
- Extended proprietary
coverage, leveraging the INNERCAP patent
portfolio.
- Technological entry
barriers.
- Optimize bioavailability.
- Enhance patient
compliance.
- Targeted point of
active release.
- Product Enhancement.
|
- Incompatible complementary materials
combined.
- Controlled dissolution profiles.
- pH release coatings.
- Increases options of actives and release
profiles to work with in developing
improved or new chemical entities.
- Less generic competition and counterfeiting.
- Enhanced drug absorption.
|
